Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Vaccine against Ebola: Commission grants first-ever market authorisation
Today, the European Commission adopted the decision granting marketing authorisation to the company Merck Sharp & Dohme B.
FDA Grants Priority Review to Opdivo-Yervoy Combo in Advanced HCC
The FDA has accepted the supplemental biologics license application and granted breakthrough therapy designation to nivolumab (Opdivo) plus ipilimumab (Yervoy) for the treatment of pat...
Roche Discontinues Trial of Duchenne Muscular Dystrophy Drug RG6206
Roche has discontinued a phase 2/3 trial of RG6206 after a futility analysis showed that the drug was “highly unlikely” to demonstrate clinical benefit in patients with Duchenne muscular dystrophy...
Novo Nordisk obtains exclusive worldwide licence to potential NASH candidate UD-014 from UBE Industries
Novo Nordisk A/S and UBE Industries Ltd.
Brain implants used to fight drug addiction in US
Patients with severe opioid addiction are being given brain implants to help reduce their cravings, in the first trial of its kind in the US.
FDA approves first therapy to treat patients with rare blood disorder
Today the U.
Britain's AstraZeneca to distribute Sun Pharma cancer drugs in China
BENGALURU (Reuters) - Top Indian drugmaker Sun Pharmaceutical Industries Ltd said on Wednesday Britain’s AstraZeneca would distribute some of Sun’s cancer treatment drugs in China, the wor...
The Online User Experience That Can Drive Action for Your Brand
Promoting change is difficult, so it’s empowering to learn that online health information can inspire health-improving actions.
Say hello to Roche's worst-case scenario: Teva's Rituxan biosim set to launch in U.S.
Already facing the launch of U.
Britain's AstraZeneca launches $1 billion China investment fund with CICC
SHANGHAI (Reuters) - AstraZeneca (AZN.
PredictImmune announces PredictSURE IBD study
PredictImmune, in a joint initiative with the Crohn’s & Colitis Foundation, has announced the start of a jointly-sponsored study to validate PredictSURE IBD – the company’s first prognostic ...
UPS drone makes first home prescription deliveries for CVS
LOS ANGELES (Reuters) - United Parcel Service Inc (UPS.
368
369
370
371
372
373
374
375
376
